Literature DB >> 35570226

Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.

Zhuo Chen1, Jing Wu2, Liang Wang3, Hua Zhao4, Jie He5.   

Abstract

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. More and more studies have shown that the tumor immune microenvironment (TME) of TNBC is closely related to its poor prognosis and early metastasis. We try to explain how tumor-associate macrophages (TAMs), an important component of the TME, function in the matrix of TNBC. Therefore, we induced THP-1 cells to become M1-TAMs and M2-TAMs, investigated their influence on breast cancer cells. 82 TNBC paraffin samples were made into tissue microarrays. The expression of macrophages makers were measured by immunohistochemistry. Scratch assay, Transwell assay, CCK-8 cell proliferation assay were performed in the co-culture system of breast cancer cells lines and macrophages to observe the invasion and proliferation ability of breast cancer cell lines. Western Blot (WB) was performed to detect the expression of E-cadherin (CDH1) and N-cadherin (CDH2). M2-TAMs were more numerous than M1-TAMs in the matrix of TNBC cancer nests and associated with poor prognosis. M2-TAMs promoted the invasion, migration, and proliferation of TNBC cells. M1-TAMs had inhibitory effects. In MCF-7 cells, WB showed a decrease in CDH1 and an increase in CDH2. In MDA-MB-231 cells and BT549 cells, CDH2 expression was reduced and CDH1 expression was increased. All of the above results were statistically significant, p < 0.001. M2-TAMs were more numerous in TNBC and associated with poor prognosis. M2-TAMs promoted the invasion, migration, and proliferation of breast cancer cells. The mechanism may be related to the epithelial-mesenchymal transition.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  EMT; Invasion; Proliferation; TAMs; TNBC

Mesh:

Year:  2022        PMID: 35570226     DOI: 10.1007/s12032-022-01670-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  28 in total

Review 1.  Role of Immunotherapy in Triple-Negative Breast Cancer.

Authors:  Tanya E Keenan; Sara M Tolaney
Journal:  J Natl Compr Canc Netw       Date:  2020-04       Impact factor: 11.908

2.  Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer.

Authors:  Mengmeng Niu; Solange Valdes; Youssef W Naguib; Stephen D Hursting; Zhengrong Cui
Journal:  Mol Pharm       Date:  2016-04-26       Impact factor: 4.939

3.  Breast cancer cells and macrophages in a paracrine-juxtacrine loop.

Authors:  Sevgi Onal; Merve Turker-Burhan; Gizem Bati-Ayaz; Hamdullah Yanik; Devrim Pesen-Okvur
Journal:  Biomaterials       Date:  2020-10-22       Impact factor: 12.479

4.  Macrophages orchestrate breast cancer early dissemination and metastasis.

Authors:  Nina Linde; Maria Casanova-Acebes; Maria Soledad Sosa; Arthur Mortha; Adeeb Rahman; Eduardo Farias; Kathryn Harper; Ethan Tardio; Ivan Reyes Torres; Joan Jones; John Condeelis; Miriam Merad; Julio A Aguirre-Ghiso
Journal:  Nat Commun       Date:  2018-01-02       Impact factor: 14.919

5.  Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages.

Authors:  Sean P Arlauckas; Seth B Garren; Chris S Garris; Rainer H Kohler; Juhyun Oh; Mikael J Pittet; Ralph Weissleder
Journal:  Theranostics       Date:  2018-11-12       Impact factor: 11.556

6.  IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states.

Authors:  Giulia Pellizzari; Coran Hoskin; Silvia Crescioli; Silvia Mele; Jelena Gotovina; Giulia Chiaruttini; Rodolfo Bianchini; Kristina Ilieva; Heather J Bax; Sophie Papa; Katie E Lacy; Erika Jensen-Jarolim; Sophia Tsoka; Debra H Josephs; James F Spicer; Sophia N Karagiannis
Journal:  EBioMedicine       Date:  2019-04-05       Impact factor: 8.143

Review 7.  Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages.

Authors:  Marco Orecchioni; Yanal Ghosheh; Akula Bala Pramod; Klaus Ley
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

8.  Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.

Authors:  Christine Lundgren; Pär-Ola Bendahl; Maria Ekholm; Mårten Fernö; Carina Forsare; Ute Krüger; Bo Nordenskjöld; Olle Stål; Lisa Rydén
Journal:  Breast Cancer Res       Date:  2020-12-23       Impact factor: 6.466

9.  Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarization.

Authors:  Israel Cotzomi-Ortega; Oscar Nieto-Yañez; Imelda Juárez-Avelar; Guadalupe Rojas-Sanchez; José Benito Montes-Alvarado; Julio Reyes-Leyva; Patricia Aguilar-Alonso; Miriam Rodriguez-Sosa; Paola Maycotte
Journal:  Cell Signal       Date:  2021-07-03       Impact factor: 4.315

10.  Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor.

Authors:  Sourav Paul; Sushanta Chhatar; Amrita Mishra; Girdhari Lal
Journal:  J Immunother Cancer       Date:  2019-08-06       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.